Well-defined single-atom catalytic
(SAC) sites with unique geometric
and electronic properties are at the forefront of catalyst research.
One type of SAC is a so-called dilute limit alloy (DLA), where single-metal
atom sites are supported on (or in) the surface of a second metal.
This contribution explores the simple and scalable approach of strong
electrostatic adsorption (SEA) to synthesize silica-supported DLA
of palladium on copper. The catalysts were characterized using X-ray
diffraction, temperature-programmed reduction, and transmission electron
microscopy images to confirm the presence of tightly distributed metal
nanoparticles. The isolated Pd sites on Cu were probed using transmission
Fourier-transform infrared (FTIR) spectroscopy during adsorption of
CO. Through spectral curve fitting to extract Gaussian peak parameters,
coupled with density functional theory (DFT) calculations, the nature
and structure of the Pd sites were determined. In addition to typical
vibrational features observed for CO on copper, three additional peaks
at 2046, 2021, and 1908 cm–1 were observed for the
DLA Pd–Cu system. The DFT analysis of the same system showed
that these peaks are consistent with CO linearly adsorbed on an embedded
palladium atom on a Cu(100) surface, a Pd on a Cu(111) surface, and
a bridge CO between Pd and Cu with the Pd embedded on a Cu(211) surface.
Experimental and computation trends in CO vibration wavenumbers could
be well interpreted using the Dewar–Chatt–Duncanson
(DCD) model. The promise of the SEA approach for producing DLAs and
the utility of this combined FTIR/DFT approach for their characterization
will be discussed in light of these findings.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.